Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Breast Cancer × Aromatase Inhibitors × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 17 Neoplasms, Hormone-Dependent 2 Carcinoma, Lobular 2 Carcinoma, Ductal, Breast 2 Polycystic Ovary Syndrome 1 Breast Cancer Metastatic 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 4 Anastrozole 4 Letrozole 2 Goserelin 2 exemestane 1 entinostat 1 apatinib 1 Paclitaxel 1 Injections 1 FCN-437c 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06447623 2024-06-07

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Fudan University

Phase 3 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡